Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Alrosa updated the capex assessment of the Mir mine

1/26/24 ALRS

Rosbank to change its head and update its strategy

1/26/24 ROSB

Marketplace Magnit Market will start operating in the first half of 2024

1/26/24 MGNT

MTS established a company to develop electronics for the automotive industry

1/26/24 MTSS

Kamaz increased sales of passenger vehicles

1/26/24 KMAZ

Fesco increased transportation between China and Vladivostok

1/26/24 FESH

MMK's Turkish plant more than halves steel production in 2023

1/26/24 MAGN

First shipment from Arctic LNG 2 is scheduled for February

1/26/24 NVTK

Monopoly excluded Cyprus Glazifer from the chain of ownership of Globaltruck

1/25/24 GTRK

Rosneft plans to expand its presence in the Indian market

1/25/24 ROSN